184PCAM-H2 effectively targets and treats HER2 positive...

Annals of Oncology 2019 / 05 Vol. 30; Iss. Supplement

184PCAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab

Puttemans, J, D’Huyvetter, M, Windhorst, B, Lahoutte, T, Devoogdt, N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz100.035
Date:
May, 2019
File:
PDF, 77 KB
english, 2019
Conversion to is in progress
Conversion to is failed